MMC Benefits Handbook
Utilization Review
Which utilization review services are offered?
The Plan offers preauthorization and case management review.
You may obtain more information about these review services by calling the Claims Administrator.
What is Preauthorization?
Preauthorization is a utilization review service performed by licensed healthcare professionals. The intent is to determine medical necessity and appropriateness of proposed treatment, including level of care, benefit coverage and eligibility.
In many cases, your Non-Network Benefits will be reduced if the Claims Administrator has not provided preauthorization.
What services require preauthorization?
The following types of medical expenses require preauthorization:
  • Inpatient Admission:
    • Inclusive of all Acute Inpatient, Acute Rehabilitation, Skilled Nursing Facility, Long Term Acute Rehab, and OB delivery stays beyond the Federal Mandate minimum LOS (including newborn stays beyond the mother's stay)
    • Emergency Admissions (Requires Plan notification no later than 2 business days after admission
  • Diagnostic Testing:
    • BRCA Genetic Testing
    • Chromosomal Microarray Analysis (CMA) for Developmental Delay, Autism Spectrum Disorder, Intellectual Disability and Congenital Anomalies
    • Gene Expression Profiling for Managing Breast Cancer Treatment
    • Gene Mutation Testing for Cancer Susceptibility and Management
    • Genetic Testing for Inherited Diseases
    • Genetic Testing for Lynch Syndrome, Familial Adenomatous Polyposis (FAP) Attenuated FAP and MYH-Associated Polyposis
    • Preimplantation Genetic Diagnosis Testing
    • Prostate Saturation Biopsy
    • Testing for Biochemical Markers for Alzheimer's Disease
    • Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling
    • Wireless Capsule for the Evaluation of Suspected Gastric and Intestinal Motility Disorders
  • Durable Medical Equipment (DME/Prosthetics):
    • Augmentative and Alternative Communication (AAC) Devices with Digitized or Synthesized Speech Output
    • Compression Devices for Lymphedema
    • Electric Tumor Treatment Field (TTF)
    • External Upper Limb Stimulation for the Treatment of Tremors
    • Functional Electrical Stimulation (FES); Threshold Electrical Stimulation (TES)
    • High Frequency Chest Compression Devices for Airway Clearance
    • Implantable Infusion Pumps
    • Intrapulmonary Percussive Ventilation Device
    • Microprocessor Controlled Knee-Ankle-Foot Orthosis
    • Microprocessor Controlled Lower Limb Prosthesis
    • Myoelectric Upper Extremity Prosthetic Devices
    • Neuromuscular Electrical Training for the Treatment of Obstructive Sleep Apnea or Snoring
    • Noninvasive Electrical Bone Growth Stimulation of the Appendicular Skeleton
    • Robotic Arm Assistive Devices
    • Standing Frames
    • Ultrasonic Diathermy Devices
    • Ultrasound Bone Growth Stimulation
    • Powered Wheeled Mobility DevicesBRCA Genetic Testing
    • Chromosomal Microarray Analysis (CMA) for Developmental Delay, Autism Spectrum Disorder, Intellectual Disability and
  • Gender Affirming Surgery
  • Human Organ and Bon Marrow/Stem Cell Transplant
    • Inpatient admits for ALL solid organ and bone marrow/stem cell transplants (Including Kidney only transplants)
    • Outpatient: All procedures considered to be transplant or transplant related including but not limited to:
    • Donor Leukocyte Infusion
    • Intrathecal treatment of Spinal Muscular Atrophy (SMA) Spinraza (nusinersen)
    • Stem Cell/Bone Marrow transplant (with or without myeloablative therapy)
  • CAR T-cell immunotherapy treatment including but not limited to:
    • Axicabtagene ciloleucel (Yescarta™)
    • Amtagvi (lifileucel)
    • Brexucabtagene Autoleucel (Tecartus)
    • Carvykti (ciltacabtagene autoleucel)
    • idecabtagene vicleucel (Abecma)
    • lisocabtagene maraleucel (Breyanzi)
    • Tisagenlecleucel (Kymriah™)
  • Gene Replacement Therapy including but not limited to:
    • Gene Therapy for Ocular Conditions/ Voretigene neparvovec-rzyl (Luxturna™)
    • Gene Therapy for Spinal Muscular Atrophy/ onasemnogene abeparvovec-xioi (Zolgensma®)
    • Gene Therapy for Hemophilia
    • Gene Therapy for Beta Thalassemia Betibeglogene autotemcel (ZYNTEGLO)
    • Gene Therapy for Cerebral Adrenoleukodystrophy (CALD)
    • Gene Therapy for Duchenne Muscular Dystrophy
    • Gene Therapy for Sickle Cell Disease
    • Gene Therapy for Metachromatic Leukodystrophy
  • Mental Health/Substance Abuse (MHSA):
    • Acute Inpatient Admissions
    • Transcranial Magnetic Stimulation (TMS)
    • Residential Care
    • Behavioral Health in-home Programs
    • Applied Behavioral Analysis (ABA)
    • Intensive Outpatient Therapy (IOP)
    • Partial Hospitalization (PHP)
  • Other Outpatient and Surgical Services:
    • Aduhelm (aducanumab)
    • Ambulance Services: Air and Water (excludes 911 initiated emergency transport)
    • Ablative Techniques as a Treatment for Barrett's Esophagus
    • Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting
      • Insertion/injection of prosthetic material collagen implants
    • Axial Lumbar Interbody Fusion
    • Balloon Sinus Ostial Dilation
    • Bariatric Surgery and Other Treatments for Clinically Severe Obesity-
    • Blepharoplasty, Blepharoptosis Repair, and Brow Lift
    • Bone-Anchored and Bone Conduction Hearing Aids
    • Breast Procedures; including Reconstructive Surgery, Implants and other Breast Procedures
    • Bronchial Thermoplasty
    • Cardiac Contractility Modulation Therapy
    • Cardiac Resynchronization Therapy (CRT) with or without an Implantable Cardioverter Defibrillator (CRT/ICD) for the Treatment of Heart Failure
    • Carotid, Vertebral and Intracranial Artery Stent Placement with or without Angioplasty
    • Cardioverter Defibrillators
    • Cellular Therapy Products for Allogeneic Stem Cell Transplantation
    • Cervical and Thoracic Discography
    • Cochlear Implants and Auditory Brainstem Implants
    • Corneal Collagen Cross-Linking
    • Cosmetic and Reconstructive Services: Skin Related, including but not limited to:
      • Brachioplasty
      • Chin Implant, Mentoplasty, Osteoplasty Mandible
      • Procedures Performed on the Face, Jaw or Neck (including facial dermabrasion, scar revision)
    • Cosmetic and Reconstructive Services of the Head and Neck, including but not limited to:
      • Facial Plastic Surgery Otoplasty - Rhinophyma
      • Rhinoplasty or Rhinoseptoplasty (procedure which combines both rhinoplasty and septoplasty)
      • Rhytidectomy (Face lift)
      • Cranial Nerve Procedures
      • Ear or Body Piercing
      • Frown Lines
      • Neck Tuck (Submental Lipectomy)
    • Cosmetic and Reconstructive Services of the Trunk and Groin, including but not limited to:
      • Brachioplasty
      • Buttock/Thigh Lift
      • Congenital Abnormalities
      • Lipectomy/Liposuction
      • Repair of Pectus Excavatum/Carinatum
      • Procedures on the Genitalia
    • Cryosurgical Ablation of Solid Tumors Outside the Liver
    • Deep Brain, Cortical, and Cerebellar Stimulation
    • Diaphragmatic/Phrenic Nerve Stimulation and Diaphragm Pacing Systems
    • Doppler-Guided Transanal Hemorrhoidal Dearterialization
    • Electrophysiology-Guided Noninvasive Stereotactic Cardiac Radioablation
    • Endovascular Techniques (Percutaneous or Open Exposure) for Arterial Revascularization of the Lower Extremities)
    • Extraosseous Subtalar Joint Implantation and Subtalar Arthroereisis
    • Focal Laser Ablation for the Treatment of Prostate Cancer
    • Functional Endoscopic Sinus Surgery (FESS)
    • Home Parenteral Nutrition
    • Hyperbaric Oxygen Therapy (Systemic/Topical)
    • Immunoprophylaxis for respiratory syncytial virus (RSV)/ Synagis (palivizumab)
    • Implantable Ambulatory Event Monitors and Mobile Cardiac Telemetry
    • Implanted Devices for Spinal Stenosis
    • Implanted (Epidural and Subcutaneous) Spinal Cord Stimulators (SCS)
    • Implanted Artificial Iris Devices
    • Implanted Port Delivery Systems to Treat Ocular Disease
    • Implantable Infusion Pumps
    • Implantable Peripheral Nerve Stimulation Devices as a Treatment for Pain
    • Implantable Shock Absorber for Treatment of Knee Osteoarthritis
    • Intracardiac Ischemia Monitoring
    • Intraocular Anterior Segment Aqueous Drainage Devices (without extraocular reservoir)
    • Keratoprosthesis
    • Leadless Pacemaker
    • Locoregional and Surgical Techniques for Treating Primary and Metastatic Liver Malignancies
    • Lower Esophageal Sphincter Augmentation Devices for the Treatment of Gastroesophageal Reflux Disease (GERD)
    • Lysis of Epidural Adhesions
    • Mandibular/Maxillary (Orthognathic) Surgery
    • Manipulation Under Anesthesia
    • Mastectomy for Gynecomastia
    • Mechanical Circulatory Assist Devices (Ventricular Assist Devices, Percutaneous Ventricular Assist Devices and Artificial Hearts)
    • Meniscal Allograft Transplantation of the Knee
    • Minimally Invasive Treatment of the Posterior Nasal Nerve to Treat Rhinitis
    • Nasal Surgery for the Treatment of Obstructive Sleep Apnea and Snoring
    • Oral, Pharyngeal and Maxillofacial Surgical Treatment for Obstructive Sleep Apnea or Snoring
    • Outpatient Cardiac Hemodynamic Monitoring Using a Wireless Sensor for Heart Failure Management
    • Panniculectomy and Abdominoplasty
    • Partial Left Ventriculectomy
    • Patent Foramen Ovale and Left Atrial Appendage Closure Devices for Stroke Prevention
    • Penile Prosthesis Implantation
    • Percutaneous and Endoscopic Spinal Surgery
    • Percutaneous Neurolysis for Chronic Neck and Back Pain
    • Percutaneous Vertebral Disc and Vertebral Endplate Procedures
    • Percutaneous Vertebroplasty, Kyphoplasty and Sacroplasty
    • Perirectal Spacers for Use During Prostate Radiotherapy
    • Presbyopia and Astigmatism-Correcting Intraocular Lenses
    • Private Duty Nursing in the Home Setting
    • Reduction Mammaplasty
    • Sacral Nerve Stimulation (SNS) and Percutaneous Tibial Nerve Stimulation (PTNS) for Urinary and Fecal Incontinence and Urinary Retention
    • Sacral Nerve Stimulation as a Treatment of Neurogenic Bladder Secondary to Spinal Cord Injury
    • Sacroiliac Joint Fusion, Open
    • Self-Expanding Absorptive Sinus Ostial Dilation
    • Sipuleucel-T (Provenge®) Autologous Cellular Immunotherapy for the Treatment of Prostate Cancer
    • Surgical and Ablative Treatments for Chronic Headaches
    • Therapeutic Apheresis
    • Total Ankle Replacement
    • Transcatheter Ablation of Arrhythmogenic Foci in the Pulmonary Veins
    • Transcatheter Heart Valve Procedures
    • Transendoscopic Therapy for Gastroesophageal Reflux Disease, Dysphagia and Gastroparesis
    • Transmyocardial/Perventricular Device Closure of Ventricular Septal Defects
    • Treatment of Osteochondral Defects
    • Treatment of Temporomandibular Disorders
    • Treatments for Urinary Incontinence
    • Treatment of Varicose Veins (Lower Extremities)
    • Vagus Nerve Stimulation
    • Ovarian and Internal Iliac Vein Embolization as a Treatment of Pelvic Congestion Syndrome and Varicocele
    • Venous Angioplasty with or without Stent Placement/ Venous Stenting
    • Viscocanalostomy and Canaloplasty
    • Wireless Cardiac Resynchronization Therapy for Left Ventricular Pacing
    • Wearable Cardioverter-Defibrillator
  • Out of Network Referrals:
Out of Network Services for consideration of payment at in-network benefit level (may be authorized, based on network availability and/or medical necessity.)
  • Radiation Therapy/Radiology Services:
    • Absolute Quantitation of Myocardial Blood Flow Measurement
    • Catheter-based Embolization Procedures for Malignant Lesions Outside the Liver
    • Cryosurgical or Radiofrequency Ablation to Treat Solid Tumors Outside the Liver
    • Intensity Modulated Radiation Therapy (IMRT)
    • MRI Guided High Intensity Focused Ultrasound Ablation for Non-Oncologic Indications
    • Proton Beam Therapy
    • Radioimmunotherapy and Somatostatin Receptor Targeted Radiotherapy (Azedra, Lutathera, Pluvicto, Zevalin)
    • Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT)
    • Wireless Capsule Endoscopy for Gastrointestinal Imaging and the Patency Capsule
    • Xofigo (Radium Ra 223 Dichloride)
If you have an emergency hospital admission, surgery or specified procedure, you, a family member, your physician or the hospital must preauthorize within 48 hours of service.
If the procedure or treatment is performed for any condition other than an emergency condition, the call must be made at least 15 days before the date the procedure is to be performed or the treatment is to start. If it is not possible to make the call during the specified time, it must be made as soon as reasonably possible before the date the procedure or treatment is to be performed.
If you are receiving an infused medication, certain medications may require use of the lowest cost site of care.
Do I need to have my maternity coverage preauthorized?
No. Preauthorization within 48 hours is not required for the initial hospital admission.
You must notify the preauthorization service if the mother or her newborn stay in the hospital longer than 48 hours after a vaginal delivery or 96 hours after a Cesarean birth. This notification must occur within 24 hours of the determination to extend the stay.
When do I obtain preauthorization?
You, your family member or health care professional must obtain preauthorization as soon as you know you need a service requiring preauthorization, but not less than 15 days prior to the procedure or treatment.
Note: You are responsible for ensuring your service has been preauthorized.
How do I obtain preauthorization?
Initiate the preauthorization process by calling the Claims Administrator.
What happens if I fail to obtain preauthorization?
If you fail to obtain preauthorization, there will be no penalty.
You are responsible for preauthorizing out-of-network services only. Your in-network provider will preauthorize all other services related to inpatient admissions, but you are responsible for authorizing all other required services.
Note: To receive coverage for infertility-related treatments and services, you MUST use a provider in WIN's provider network and obtain required preauthorization.
What approvals do I need if I am going into the hospital?
You must obtain preauthorization as soon as possible but at least 15 days before you are admitted for a non-emergency hospital admission or stay.
If you have an emergency hospital admission, surgery or specified procedure, you, a family member, your physician or the hospital must preauthorize within 48 hours of the service.
Case Management Review
When the preauthorization service identifies a major medical condition, that condition will be subject to case management review. Case management review aims at identifying major medical conditions early in the treatment plan and makes recommendations regarding the medical necessity of requested health care services.
Case managers with experience in intensive medical treatment and rehabilitation provide case management services. The case manager works with the patient's physician to identify available resources and develop the best treatment plan. In addition, the case manager can coordinate the various caregivers, such as occupational or physical therapists, required by the patient.
Situations that may benefit from case management include severe illnesses and injuries such as:
  • Head trauma
  • Organ transplants
  • Burn cases
  • Neo-natal high risk infants
  • Multiple fractures
  • HIV-related conditions
  • Brain injuries
  • Cancer
  • Prolonged illnesses
  • Degenerative neurological disorders (e.g. multiple sclerosis).
To best help the patient, the case managers should be involved from the earliest stages of a major condition. This service gives you access to a knowledgeable case manager who will use his or her expertise to assist you and your physician in considering your treatment options.
If the case managers questions the necessity of the proposed hospital admission or procedure, a physician advisor may contact your physician to discuss your case and suggest other treatment options that are generally utilized for your condition. You, your physician, and the case manager will be informed of the outcome of the review, and the Claims Administrator will determine the level of benefit coverage you will receive. You and your physician will be notified of the utilization reviewer's recommendation by telephone and in writing. You will also be informed of the appeal process if the procedures your physician ultimately recommends are not covered under the Plan (as determined by the Claims Administrator).